# Efficacy and safety of apalutamide in metastatic castration sensitive prostate cancer patients with a prior history of cardiovascular or metabolic risk factors: A post-hoc analysis of the TITAN study.

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/efficacy-and-safety-of-apalutamide-in-metastatic-castration-sensitive-prostate/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Arun Azad,Dingwei Ye,Hiroji Uemura,Amitabha Bhaumik,Michael Eisbacher,Anildeep Singh,Sharon McCarthy,Suneel Mundle,Kim N.,Neeraj Agarwal |
| Citations | 1 |
| DOI | 10.1200/jco.2025.43.5_suppl.165 |
| Fields | Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W4407702418 |
| Type | conference-abstract |
| Year | 2025 |

## Paper authors

- [Anildeep Singh](https://scholariq.org/researchers/anildeep-singh/)

## Paper journal

- [Journal of Clinical Oncology](https://scholariq.org/journals/journal-of-clinical-oncology/)

## Paper primary topic

- [Prostate Cancer Treatment and Research](https://scholariq.org/topics/prostate-cancer-treatment-and-research/)

## Paper topics

- [Prostate Cancer Treatment and Research](https://scholariq.org/topics/prostate-cancer-treatment-and-research/)
- [Radiopharmaceutical Chemistry and Applications](https://scholariq.org/topics/radiopharmaceutical-chemistry-and-applications/)
- [Boron Compounds in Chemistry](https://scholariq.org/topics/boron-compounds-in-chemistry/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.